期刊文献+

益气通络汤对C5b-9诱导足细胞损伤及IL-1β水平的影响 被引量:1

Yiqi Tongluo Decoction inhibits apoptosis induced by C5b-9 in podocytes and its effect on IL-1βlevel
下载PDF
导出
摘要 目的探讨益气通络汤对体外膜攻击复合物(C5b-9)诱导的小鼠肾足细胞损伤模型的干预作用,以期明确益气通络汤在膜性肾病治疗中的作用。方法将小鼠足细胞(MPC5)完全随机分为空白对照组,模型组,低、中、高剂量含药血清组,厄贝沙坦组。以C5b-9(0.8μg/mL)诱导培养的MPC5细胞建立足细胞损伤模型。CCK-8法检测益气通络汤对损伤足细胞活性的影响;微板法测定乳酸脱氢酶(LDH)活性,检测益气通络汤对足细胞损伤的影响;流式细胞术检测益气通络汤对足细胞凋亡的影响;双抗体夹心法(ELISA法)测定白细胞介素1β(IL-1β)水平;流式细胞仪检测活性氧(ROS)荧光强度,检测益气通络汤对足细胞氧化应激的影响。结果低、中、高剂量含药血清组和厄贝沙坦组足细胞OD值均大于模型组,差异均有统计学意义(P<0.05)。低、中、高剂量含药血清组和厄贝沙坦组LDH水平均低于模型组,差异均有统计学意义(P<0.05)。低、中、高剂量含药血清组和厄贝沙坦组足细胞晚期细胞凋亡百分比均低于模型组,差异均有统计学意义(P<0.05)。正常的活细胞不被Annexin V-FITC和碘化丙啶(PI)染色;凋亡早期的细胞仅被Annexin V-FITC染色,PI染色呈阴性;凋亡晚期的细胞可以同时被Annexin V-FITC和PI染色;坏死细胞不能被Annexin V-FITC染色,只能被PI染色。低、中、高剂量含药血清组和厄贝沙坦组足细胞炎症因子IL-1β的OD值均小于模型组,差异均有统计学意义(P<0.05)。低、中、高剂量含药血清组和厄贝沙坦组足细胞ROS荧光强度均低于模型组,差异均有统计学意义(P<0.05)。结论益气通络汤可以减轻足细胞损伤,对足细胞活性有正向诱导作用,且能够提高足细胞的抗氧化能力,其可能是通过抑制足细胞的氧化应激、细胞凋亡和炎症反应等途径实现的。 Objective This paper aims to investigate the effect of Yiqi Tongluo Decoction on renal podocyte injury induced by extracorporeal complement membrane attack complex(C5b-9)in mice and to clarify its effect in the treatment of membranous nephropathy.Methods Mouse podocyte clone 5(MPC5)was randomly assigned to a blank control group,a model group,low,medium-and high-dose medicated serum groups,and an irbesartan group.A podocyte injury model was established by treating cultured MPC5 with C5b-9(0.8μg/mL).CCK-8 assay was used to detect the effect of Yiqi Tongluo Decoction on the activity of injured podocytes;lactate dehydrogenase(LDH)activity was measured by microplate assay to detect its effect on podocyte injury;flow cytometry was used to detect its effect on podocyte apoptosis;double-antibody sandwich assay(ELISA)was used to determine interleukin 1β(IL-1β)levels;reactive oxygen species(ROS)fluorescence intensity was measured by flow cytometry to detect its effect on oxidative stress in podocytes.Results The OD values of podocytes in low,medium,and high-dose medicated serum groups and the irbesartan group were significantly higher than those in the model group(P<0.05).LDH levels in the low,medium,and high-dose medicated serum groups and the irbesartan group were significantly lower than those in the model group(P<0.05).The percentages of late podocyte apoptosis in the low,medium,and high-dose medicated serum groups and irbesartan group were significantly lower than those in the model group(P<0.05).normal viable cells are not stained by Annexin V-FITC and propidium iodide(PI);cells in the early stage of apoptosis only stained by Annexin V-FITC and stained negatively by propidium iodide;cells in the late stage of apoptosis can be stained by Annexin V-FITC and PI simultaneously;necrotic cells cannot be stained by Annexin V-FITC and can only be stained by PI.The OD values of IL-1β,an inflammatory factor in podocytes,in the low,medium,and high-dose medicated serum groups and irbesartan group were significantly lower than those in the model group(P<0.05).ROS fluorescence intensity in podocytes was significantly lower in the low,medium,and high-dose medicated serum groups and irbesartan group than in the model group(P<0.05).Conclusion Yiqi Tongluo Decoction can reduce podocyte injury,positively induce podocyte activity,and improve the antioxidant capacity of podocytes.The mechanism may be through inhibiting oxidative stress,apoptosis,and inflammatory response pathways of podocytes.
作者 甘露 杨震 张春戬 李莹 郝芳艺 董壮 郑佳新 Ganlu;Yang Zhen;Zhang Chunjian;Li Ying;Hao Fangyi;Dong Zhuang;Zheng Jiaxin(Heilongjiang Academy of Chinese Medical Sciences,Harbin 150036,China;Department of Nephrology,The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine,Harbin 150001,China)
出处 《保健医学研究与实践》 2023年第9期1-7,F0002,共8页 Health Medicine Research and Practice
基金 黑龙江省重点研发计划项目(2022ZX06C16) 黑龙江省中医药科研项目(ZHY2020-049)。
关键词 益气通络汤 足细胞损伤 细胞凋亡 炎症因子 Yiqi Tongluo Decoction Podocyte injury Apoptosis Inflammatory factors
  • 相关文献

参考文献8

二级参考文献129

  • 1毛竞宇,刘昊,辛鑫,陈素枝,赵美姣,檀淼,杨凤文,檀金川.益肾通络方对低中危特发性膜性肾病患者肾小管功能的影响[J].中药药理与临床,2022,38(2):202-206. 被引量:4
  • 2王玉洁,曹灵,胡承刚,彭素英,丁文飞,秦建华.川芎嗪对膜性肾病的治疗作用及对内质网应激的拮抗[J].中药材,2021,44(5):1213-1218. 被引量:4
  • 3李毅,何胜强,代能捷,刘新国.芪龙通肾方通过调节TGF-β1Smads通路对C-BSA诱导膜性肾病大鼠的改善作用[J].四川中医,2022,40(3):55-60. 被引量:2
  • 4章友康 王海燕 朱世乐 等.黄芪和当归治疗三种病理类型肾炎的实验研究[J].中华内科杂志,1986,25(4):222-225.
  • 5王振刚.黄芪的免疫药理学研究[A]..中药药理与临床研究进展:第1版[C].北京:中国科学技术出版社,1992.254.
  • 6Cunningham PN, Hack BK, Ren G, et al. Glomerular complement regulation is overwhelmed in passive Heymann nephritis. Kidney Int, 2001,60:900.
  • 7Sogabe H, Nangaku M, Ishibashi Y, et al. Increased susceptibility of decay-accelerating factor deficient mice to anti-glomerudar basement membrane glomerulonephritis. J Immunol, 2001,167:2791.
  • 8Kojima K, Matsui K, Nagase M. Protection of a(3) integrin-mediated podocyte shape by superoxide dismutase in the puromycin aminonucleoside nephrosis rat. Am J Kidney Dis, 2000,35:1175.
  • 9Grone HJ, Walli AK, Grone EF. The role of oxidatively modified lipoproteins in lipid nephropathy. Contrib Nephrol, 1997,120:160.
  • 10Kerjaschki D, Neale TJ. Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy (Heymann nephritis). J Am Soc Nephrol, 1996,7:2518.

共引文献67

同被引文献16

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部